Transkaryotic, Hoechst Marion Roussel Inc. deal

TKTX received a $2 million milestone from partner HMR

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE